top of page
TIMELINE_TXT.png
Amazentis announces new clinical findings and launches first consumer product with Mitopure (proprietary highly pure Urolithin A) in the USA. 

Amazentis is an innovative life science company dedicated to employing breakthrough research and clinical science to bring advanced therapeutic nutrition products to life.

Who we are

We employ rigorous science

to pioneer the discovery and clinical development of the next generation of naturally derived bioactives, starting with Mitopure™ (a proprietary highly pure Urolithin A)Our focus is the development of innovative products designed to meet the health needs of an aging population. Our current work builds on modulating Mitochondrial function.

Science
Muscle Health

We are improving muscle health

Our most advanced product targets the reversal of age-related muscle decline by improving the activity of mitochondria – the “powerhouse of the cell” – to optimize muscle function.

 

Society is aging. Worldwide,
it’s projected there will be more than 1 billion people over 65 years old by 2030. 

A decline in skeletal muscle strength and overall function is a hallmark of aging. These changes can become debilitating and lead to a condition called sarcopenia, which is thought to affect 30% of elderly.

Target

We are targeting a novel pathway

Our lead bioactive - a metabolite of pomegranates - has been demonstrated to trigger a highly effective biological mechanism of action that recycles and rejuvenates aging mitochondria via a process called mitophagy.

Leadership

Our leadership

Includes world class scientists and medical professionals.
Our board features leading members of the Life Science and Pharmaceutical industries.

Patrick Aebischer, MD
Chairman and Co-Founder

 

Chris Rinsch, PhD
CEO and Co-Founder

 

Pierre Landolt
Co-Founder

 

Greg Behar
CEO of Nestlé Health Science

 

Odile Rundquist, PhD

 

Thierry Lombard
 

Eric Lohrer
 

News

Press releases

 Amazentis Announces the Launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos 

Amazentis  l  Press Release  l  January 23rd 2020

First Human Clinical Trial Results on the Anti-Aging Compound, Urolithin A, Published by Amazentis and Researchers from the EPFL and SIB

Amazentis  l  Press Release  l  June 14th 2019

Nestlé Health Science invests in global strategic partnership with Amazentis to develop its new cellular nutrient Urolithin A

Amazentis  l  Press Release  l  April 2nd 2019

Amazentis SA Announces Completion of Series C Financing

Amazentis Also Announces Initiation of Two Pivotal, Phase 2 Clinical Studies in North America

Amazentis  l  Press Release  l  March 21st 2018

Amazentis SA Announces Successful Phase 1A/1B Study Results in Healthy Elderly Subjects with the Food Metabolite Urolithin A

Amazentis  l  Press Release  l  April 27th 2017

Milestone Study on Pomegranate Anti-Aging Mechanism Reported

by Amazentis SA and EPFL Researchers

Amazentis  l  Press Release  l  July 11th 2016

Pomegranate finally reveals its powerful anti-aging secret /

La grenade révèle une puissante molécule anti-vieillissement

EPFL  l  Press Release  l  July 11th 2016

Pomegranates reveal its powerful anti-aging secret

 

EPFL  l  Video  l  July 6th 2016

News
Press releases

News

Press releases

 Amazentis Launches Timeline™ powered by Mitopure™
A Breakthrough in Cellular Nutrition 

Amazentis  l  Press Release  l  July 27th 2020

 Amazentis Announces the Launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos 

Amazentis  l  Press Release  l  January 23rd 2020

First Human Clinical Trial Results on the Anti-Aging Compound, Urolithin A, Published by Amazentis and Researchers from the EPFL and SIB

Amazentis  l  Press Release  l  June 14th 2019

Nestlé Health Science invests in global strategic partnership with Amazentis to develop its new cellular nutrient Urolithin A

Amazentis  l  Press Release  l  April 2nd 2019

Amazentis SA Announces Completion of Series C Financing

Amazentis Also Announces Initiation of Two Pivotal, Phase 2 Clinical Studies in North America

Amazentis  l  Press Release  l  March 21st 2018

Amazentis SA Announces Successful Phase 1A/1B Study Results in Healthy Elderly Subjects with the Food Metabolite Urolithin A

Amazentis  l  Press Release  l  April 27th 2017

Milestone Study on Pomegranate Anti-Aging Mechanism Reported

by Amazentis SA and EPFL Researchers

Amazentis  l  Press Release  l  July 11th 2016

Pomegranate finally reveals its powerful anti-aging secret /

La grenade révèle une puissante molécule anti-vieillissement

EPFL  l  Press Release  l  July 11th 2016

Pomegranates reveal its powerful anti-aging secret

 

EPFL  l  Video  l  July 6th 2016

News

Press releases

 New Clinical Study Shows Mitopure (Urolithin A) Significantly Improves Muscle Endurance in Older Adults Published in JAMA Network Open

Amazentis  l  Press Release  l  January 21st 2022

 Amazentis Pioneers First Sports Nutrition Program

and Clinical Trial in Top Athletes with Mitopure™

Amazentis  l  Press Release  l  May 11th 2021

 Amazentis Launches Timeline™ powered by Mitopure™
A Breakthrough in Cellular Nutrition 

Amazentis  l  Press Release  l  July 27th 2020

 Amazentis Announces the Launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos 

Amazentis  l  Press Release  l  January 23rd 2020

First Human Clinical Trial Results on the Anti-Aging Compound, Urolithin A, Published by Amazentis and Researchers from the EPFL and SIB

Amazentis  l  Press Release  l  June 14th 2019

Nestlé Health Science invests in global strategic partnership with Amazentis to develop its new cellular nutrient Urolithin A

Amazentis  l  Press Release  l  April 2nd 2019

Amazentis SA Announces Completion of Series C Financing

Amazentis Also Announces Initiation of Two Pivotal, Phase 2 Clinical Studies in North America

Amazentis  l  Press Release  l  March 21st 2018

Amazentis SA Announces Successful Phase 1A/1B Study Results in Healthy Elderly Subjects with the Food Metabolite Urolithin A

Amazentis  l  Press Release  l  April 27th 2017

Milestone Study on Pomegranate Anti-Aging Mechanism Reported

by Amazentis SA and EPFL Researchers

Amazentis  l  Press Release  l  July 11th 2016

Pomegranate finally reveals its powerful anti-aging secret /

La grenade révèle une puissante molécule anti-vieillissement

EPFL  l  Press Release  l  July 11th 2016

Pomegranates reveal its powerful anti-aging secret

 

EPFL  l  Video  l  July 6th 2016

News

In the media

Pomegranate compound with anti-aging effects passes human trial

medicalxpress  l  Published online  l  June 17th 2019

The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans

Nature Metabolism  l  Published online  l  June 14th 2019

Nestle Deal Seeks to Tap Pomegranate's Anti-Aging Potential

Bloomberg  l  Published online  l  April 2nd 2019

Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents

Nature Medicine  l  Published online  l  July 11th 2016

Pomegranate by-product boosts muscles and may fight ageing

New Scientist  l  Published online  l  July 11th 2016

Gut bacteria unleash anti-aging power of pomegranates

Medical News Today  l  Published online  l  July 11th 2016

Discovery of pomegranate's anti-ageing molecule is a 'milestone'

Telegraph  l  Published online  l  July 11th 2016

Amazentis va commercialiser la «vitamine C» de l’anti-âge

Bilan  l  Published online  l  July 11th 2016

Pomegranate by-product boosts muscles and may fight ageing

Financial Times  l  Published online  l  July 12th 2016

Pomegranate could help you live longer

The Times  l  Published online  l  July 12th 2016

Pomegranates Yield Promising Anti-Aging Compound

Gizmodo  l  Published online  l  July 12th 2016

Granadas contra el envejecimiento muscular

El Pais  l  Published online  l  July 12th 2016

A molecule to fight ageing

Swissquote  l  Published online  l  January 2017

In the media
Contact us

Would you like to be informed when our products become available?

EPFL Innovation Park

Bâtiment C

1015 Lausanne

Switzerland

 

Product inquiries: care@timelinenutrition.com
Business inquiries: contact@amazentis.com

Terms of UsePrivacy Policy | All contents © Copyright Amazentis SA. All Rights Reserved

bottom of page